Syndromic testing with mariPOC enables simultaneous diagnosis of COVID-19, RSV, influenza and more.
Antigen tests for professional use
The mariPOC rapid tests, which identify several pathogens at once, are best suited for decentralized diagnostics, such as point-of-care testing in health centres, private clinics, as well as hospital emergency departments.
Fast and comprehensive testing guarantees correct diagnosis without delay.
Automated test system
The mariPOC test system enables rapid and accurate diagnosis in acute infections. Multiple pathogens are tested from a single clinical sample simultaneously. The quality of the results is ensured by a sophisticated internal autoverification system.
The easy-to-use test system combines specific antigen detection with a unique diagnostic technology developed in Finland.
Preparing for the flu season
Not sure if it's COVID-19, influenza or a common cold? Find out with mariPOC Respi+ test! The Respi+ is a broad test panel covering 11 pathogens for syndromic testing of respiratory tract infections. Accurate and fast diagnosis enables optimal treatment and quick isolation measures.
Respi+ test is 10 times more likely to identify the correct pathogen than COVID testing alone.
What our long-term customers say
"mariPOC tests can be used to reliably demonstrate a COVID-19 infection. We use the negative result of the antigen test when planning to end the patient's isolation period."
"When treating clients' respiratory infections and pharyngitis, a doctor sometimes needs support from laboratory tests to make the most reliable diagnosis possible and to prescribe timely treatment. For example, medical treatment for influenza and pharyngeal Streptococcal infections is more effective the earlier the treatment can be started.
mariPOC is an excellent solution for our emergency clinics. The tests screen for multiple pathogens from a single sample at a time, and the results are quickly available to the doctor. Once the pathogen is identified, the doctor can make treatment decisions within the same day."
mariPOC is available from pharmacy's health points!
mariPOC enables pharmacies and minute clinics to offer easily accessible and affordable professional flu testing for patients and employers.
News
Press Release: Pihlajalinna and ArcDia Sign Long-Term Framework Agreement on Respiratory Infection Diagnostics
Turku and Helsinki, March 5, 2026 – Healthcare service provider Pihlajalinna and leading Finnish diagnostics...
Press Release: Doctoral Dissertation: Future Pandemics Will Be Controlled with Antigen Testing – Finnish Technology Identifies Infectious Individuals
Turku, January 20, 2026 – A doctoral dissertation to be publicly examined at the University...
How acute infectious disease diagnostics shifted from PCR to antigen testing
The acute infectious disease diagnostics landscape has shifted from PCR dominance to antigen testing due...
Events
Virology days 2024
New mariPOC research results will be published at the National Virology Days in Helsinki on...
ECCMID 2022, Lisbon, Portugal
ArcDia’s mariPOC team will be present and available for meetings at ECCMID2022 in Lisbon April 23rd...
NSCMID 2021
Come meet us at NSCMID conference 2021 (3rd- 6th September, Turku)! Our team will be...
Get the latest news from ArcDia!
We send around 5 newsletters a year to keep you up-to-date on our latest news.